European journal of breast health最新文献

{"title":"Gastrointestinal Tract Metastases of Invasive Lobular Carcinoma of the Breast: An Immunohistochemical Survey Algorithm.","authors":"Baha Zengel,&nbsp;Demet Çavdar,&nbsp;Özlem Özdemir,&nbsp;Funda Taşlı,&nbsp;Murat Karataş,&nbsp;Cenk Şimşek,&nbsp;Adam Uslu","doi":"10.4274/ejbh.galenos.2022.2022-1-5","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2022.2022-1-5","url":null,"abstract":"<p><p>Invasive lobular carcinoma (ILC) accounts for almost 15% of all breast carcinomas. The potential of ILC to metastasize to the gastointestinal system is significantly greater than that of invasive ductal carcinoma. Gastric metastasis occurred in the ninth year of the follow-up in a patient who was operated on the right breast due to ILC. The patient was investigated for simultaneous masses in the stomach and colon, and a random mass was found in her right breast.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521291/pdf/ejbh-18-375.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33517993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Salvage Mastectomy Is not the Treatment of Choice for Aggressive Subtypes of Ipsilateral Breast Cancer Recurrence: A Single-Institution Retrospective Study.","authors":"Damiano Gentile,&nbsp;Andrea Sagona,&nbsp;Ruggero Spoto,&nbsp;Davide Franceschini,&nbsp;Stefano Vaccari,&nbsp;Valeriano Vinci,&nbsp;Ersilia Biondi,&nbsp;Lorenzo Scardina,&nbsp;Corrado Tinterri","doi":"10.4274/ejbh.galenos.2022.2022-5-3","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2022.2022-5-3","url":null,"abstract":"<p><strong>Objective: </strong>Patients with triple-negative (TN) or human epidermal growth factor 2 (HER2)-enriched ipsilateral breast cancer recurrence (IBCR) seem to be excluded from a second breast-conserving surgery (BCS) under the assumption that salvage mastectomy would provide better oncological outcomes. The objective of this study was to describe the clinical features of these patients, to compare the two surgical alternatives (salvage mastectomy <i>versus</i> second BCS) in terms of oncological results, and to identify independent factors influencing prognosis and surgical treatment.</p><p><strong>Materials and methods: </strong>We retrospectively reviewed all the consecutive patients with histologically confirmed TN or HER2-enriched IBCR. Disease-free survival (DFS), distant disease-free survival (DDFS), overall survival (OS), and breast cancer-specific survival (BCSS) were analyzed and compared between the two groups.</p><p><strong>Results: </strong>Eighty-five patients were affected by TN or HER2-enriched IBCR. The majority of patients (72.9%) were treated with salvage mastectomy. There was no significant difference in terms of DFS between patients receiving a second BCS or mastectomy (<i>p</i> = 0.596). However, patients undergoing a second BCS had significantly better DDFS, OS and BCSS compared to mastectomy (<i>p</i> = 0.009; <i>p</i> = 0.002; <i>p</i> = 0.001, respectively). Tumor dimension <16 mm was found to significantly increase the probability of receiving a second BCS and positively affects recurrence and survival outcomes. Salvage mastectomy represents an independent poor prognostic factor for OS and BCSS.</p><p><strong>Conclusion: </strong>Salvage mastectomy is not always necessary and it does not seem to increase survival compared to a second BCS. In patients with small aggressive subtypes of IBCR, a second conservative approach can still be evaluated and offered, presenting acceptable loco-regional control and survival.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521294/pdf/ejbh-18-315.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33517576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Health-Related Quality of Life in Women With Breast Cancer Undergoing Treatment With Hormonal Therapy - A Review Study.","authors":"Lamya Alnaim","doi":"10.4274/ejbh.galenos.2022.2022-5-8","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2022.2022-5-8","url":null,"abstract":"<p><p>This review aimed to analyze the significance and impact of health-related quality of life (QoL) in women with breast cancer undergoing treatment with hormonal therapy. This study developed a comprehensive, structured, systematic search strategy to identify literature related to health and QoL in breast cancer patients undergoing treatment with hormonal therapy. The search was conducted for published literature indexed in PubMed (Medline), Cancer Lit, CINAHL, Google Scholar, and Web of Science between 2010 and 2020. Patients associated with the study of QoL reported some difficulties in terms of depression, anxiety, chronic fatigue, sleep problems, pain, sexual dysfunction and sleep disorders. Endocrine-related symptoms did not fluctuate between interventions and remained unchanged in all groups. The evaluation of FACT-G scores (physical well-being subscale) showed statistically significant differences among participants receiving anastrozole versus tamoxifen and exemestane. It can be concluded that the QoL of postmenopausal women with breast cancer is affected by the long-term use of adjuvant endocrine therapy, with difference reported associated with the different therapies. However, further efforts are required to improve QoL instruments and the quantitative evaluation of QoL data for patients receiving adjuvant ET.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521283/pdf/ejbh-18-292.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33517574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of Arab Cultural Barriers That Influence Muslim Arab Iraqi Women's Breast Cancer Screening Behavior.","authors":"Shadan Shukur Azeez,&nbsp;Işıl Işık Andsoy","doi":"10.4274/ejbh.galenos.2022.2022-5-6","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2022.2022-5-6","url":null,"abstract":"<p><strong>Objective: </strong>Little is known about Iraqi women's practice towards breast cancer screening (BCS), breast self-examination (BSE), clinical breast examination (CBE) and mammography, and the influence of Arab culture. The aim of this study was to assess women's behavior towards BCS, and to explain the influence of specific Arab culture barriers.</p><p><strong>Materials and methods: </strong>This descriptive study was carried out with 1,066 women. Three structured questionnaires were used in the data collection. Descriptive statistics and multivariable logistic regression were used for data evaluation.</p><p><strong>Results: </strong>Many Iraqi women did not practice regular BSE, CBE, and mammography. The most common reason was \"not having a breast complaint\". Specific Arab cultural barriers such as exposure [odds ratio (OR) = 0.545; 95% confidence interval (CI) = 0.440 to 0.674; <i>p</i><0.001], environment (OR = 0.571; 95% CI = 0.464 to 0.703; <i>p</i><0.001) and uneasiness barriers (OR = 0.736; 95% CI = 0.557 to 0.974; p=0.032) were predictors for BSE while exposure (OR = 0.553; 95% CI = 0.447 to 0.684; <i>p</i><0.001), and environment barriers (OR = 0.585; 95% CI = 0.474 to 0.772; <i>p</i><0.001) was predictor for CBE. Additionally, exposure (OR = 0.324; 95% CI = 0.251 to 0.419; <i>p</i><0.001), environment (OR = 0.636; 95% CI = 0.500 to 0.809; <i>p</i><0.001), and uneasiness barriers (OR = 0.644; 95% CI = 0.464 to 0.893; <i>p</i> = 0.008) were predictors for mammography screening of Iraqi women.</p><p><strong>Conclusion: </strong>Arab specific cultural barriers may be one of the key obstacles to BSC uptake in Iraq. Health education, including cultural education, may have the potential to increase BCS awareness and down-staging of the disease at presentation.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521288/pdf/ejbh-18-329.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33517575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Co-Existence of Two Rare Entities in the Male Breast: Intraductal Papilloma and Angiolipoma.","authors":"Murat Baykara,&nbsp;Hilal Balta,&nbsp;Erhan Cahit Özcan","doi":"10.4274/ejbh.galenos.2022.2022-1-7","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2022.2022-1-7","url":null,"abstract":"<p><p>Intraductal papilloma and angiolipoma lesions are very rare in male breasts and gynecomastia is the most common male breast pathology. A 52-year-old healthy Caucasian male patient with right nipple pain for one month and two subareolar and periareolar masses had no other abnormal clinical or laboratory findings. After ultrasound examination, pull-through excision was made with a circumareolar incision in both lesions and the samples were sent for pathological examination. Histopathological examination revealed intraductal papilloma and angiolipoma on the basis of gynecomastia. This case is unique because both lesions are extremely rare and this is the first report of concurrent occurrence in a male breast.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521292/pdf/ejbh-18-371.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33516165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Clinical, Pathological, and Prognostic Features in <i>BRCA</i> Mutant and Wild-Type Male Breast Cancer Patients.","authors":"İzzet Doğan,&nbsp;Esra Aydın,&nbsp;Hülya Yazıcı,&nbsp;Pınar Saip","doi":"10.4274/ejbh.galenos.2022.2022-5-2","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2022.2022-5-2","url":null,"abstract":"<p><strong>Objective: </strong>Published studies on male breast cancer (MBC) and <i>BRCA</i> mutations are scarce and usually include, a small number of patients. The clinicopathological characteristics of <i>BRCA</i> mutant and wild-type MBC patients were compared in more than forty patients in this study.</p><p><strong>Materials and methods: </strong>A retrospective review of MBC patients' clinical and histopathological data was conducted. To compare the patients' characteristics, chi-square test and Fisher's Exact test were utilized. Kaplan-Meier analysis was used to examine the survival analysis.</p><p><strong>Results: </strong>In total 43 cases were reviewed. The average duration of follow-up was 35.8 months. <i>BRCA</i> mutations were found in 11 (25.6%) of the patients. <i>BRCA1</i> mutations were found in four patients (9.3%), <i>BRCA2</i> mutations in six patients (14%), and <i>BRCA1</i> and <i>BRCA2</i> mutations in one patient (2.3%). The median age at diagnosis was 58 years old, and there was no statistically significant difference between groups (<i>p</i> = 0.7). Tumor location (<i>p</i> = 0.3), human epidermal growth factor receptor 2 overexpression (<i>p</i> = 0.5), estrogen receptor status (<i>p</i> = 0.05), progesterone receptor status (<i>p</i> = 0.6), tumor stage (<i>p</i> = 0.9), lymph node positivity (<i>p</i> = 0.5), tumor histology (<i>p</i> = 0.06), and recurrence status (<i>p</i> = 0.6) were similar between <i>BRCA</i>-wild type and -mutated patients. Overall survival averaged 115.6 months (range: 76.0-155.3), with no statistically significant differences between groups (<i>p</i> = 0.6).</p><p><strong>Conclusion: </strong>This study investigated clinical and pathological characteristics and prognoses of <i>BRCA</i> wild and mutant-type MBC and these were similar in all groups studied.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521287/pdf/ejbh-18-323.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33516164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes.","authors":"Selman Emiroglu,&nbsp;Mustafa Tukenmez,&nbsp;Seyma Karakus,&nbsp;Hasan Karanlik,&nbsp;Semen Onder,&nbsp;Vahit Ozmen,&nbsp;Neslihan Cabioglu,&nbsp;Enver Ozkurt,&nbsp;Ravza Yilmaz,&nbsp;Mahmut Muslumanoglu","doi":"10.4274/ejbh.galenos.2022.2022-8-1","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2022.2022-8-1","url":null,"abstract":"<p><strong>Objective: </strong>A few studies suggest that mucinous breast carcinoma (MBC) is a rare breast carcinoma with good prognostic features. Therefore, the aim of this study was to evaluate biological features and clinicopathological characteristics of pure mucinous breast carcinoma (PMBC) to determine clinical outcome in PMBC.</p><p><strong>Materials and methods: </strong>The data of 87 patients diagnosed with PMBC between November 2004 and February 2022 were retrospectively analyzed in terms of clinicopathological and demographic characteristics, management, and outcome.</p><p><strong>Results: </strong>The majority of the patients in this study were female, with a median (range) age of 63 (28-90) years. Out of 87 patients, 60 had breast conserving surgery, 27 had a mastectomy, 58 had sentinel lymph node biopsy (SLNB), and 24 had axillary dissection due to a positive SLNB or clinical axilla. Due to age and comorbidities, five patients were not suitable for axillary surgery. The median largest tumor diameter was 23 (5-100) mm. Only 23 patients (26.4%) received adjuvant chemotherapy, whereas almost all patients received hormone therapy. The median duration of follow-up was 53 (6-207) months. There was no local or systemic recurrence in any of the patients. Only 10 patients (11.5%) died from non-cancer causes during the follow-up and treatment period. In this study, tumor diameter was significantly higher in grade II/III tumors (<i>p</i> = 0.039) and in patients under the age of 50 (<i>p</i> = 0.027). Furthermore, lymph node metastasis was statistically significantly more likely in patients under the age of 50 (60% versus 40%, <i>p</i> = 0.013). Patients who had not received chemotherapy or radiotherapy tended to be older than 50 years (<i>p</i> = 0.002).</p><p><strong>Conclusion: </strong>In this study, the majority of patients were in the luminal subgroups with excellent prognosis and low incidences of lymph node metastasis. As a result, PMBC has favorable tumor biology. We believe that minimal axillary surgery would be the most appropriate approach during patient treatment, due to the low rate of lymph node involvement and favorable prognosis in PMBC patients.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521282/pdf/ejbh-18-353.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33517570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Influence of Screening Mammography Cessation and Resumption on Breast Cancer Presentation and Treatment: A Multi-Hospital Health System Experience During the Early COVID-19 Pandemic.","authors":"Holly Mason,&nbsp;Ann-Kristin Friedrich,&nbsp;Shiva Niakan,&nbsp;Danielle Jacobbe,&nbsp;Jesse Casaubon,&nbsp;Aixa Pérez Coulter","doi":"10.4274/ejbh.galenos.2022.2022-4-4","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2022.2022-4-4","url":null,"abstract":"<p><strong>Objective: </strong>To assess the impact of the coronavirus disease-2019 (COVID-19) pandemic screening restrictions on the diagnosis and treatment of breast cancer in a single health system.</p><p><strong>Materials and methods: </strong>We performed a retrospective, cohort investigation of breast cancer patients at a multi-institution health system from March 1, 2019 to December 31, 2020 with two time periods related to the pandemic: \"Early phase\" (March 18 - June 7) reflecting the time of the screening mammography moratorium and \"Late phase\" (June 8 - December 31) to reflect the time once screening mammography resumed. 2020 was compared to 2019 to exclude potential differences from temporal or seasonal changes. Variables included demographics, COVID related-deferral, cancer specific data, method of detection, type of treatment recommended and received.</p><p><strong>Results: </strong>Fewer patients presented with a breast cancer diagnosis during Early phase 2020 when compared to any other time period. Numbers increased significantly in Late phase 2020; total numbers of patients seen in 2020 approached but did not completely reach that of 2019. When compared to other time periods, patients who presented during the moratorium on screening were younger, more likely to be black, had a higher Body Mass Index, and were more likely to have a human epidermal growth factor receptor 2 positive tumor. There was a slight increase in size of presenting tumor and node positivity, although no differences in breast or axillary surgical management were identified.</p><p><strong>Conclusion: </strong>Despite an increase in tumor size and positive nodal status seen during the screening moratorium, surgical treatment was not negatively impacted.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521286/pdf/ejbh-18-306.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33517573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Significance of Radiologically Detected Small Indeterminate Extra-Mammary Lesions in Breast Cancer Patients.","authors":"Rachel Yanlin Chen, Rui Ying Goh, Hoi Ting Leung, Stephanie Cheng, Veronique Kiak Mien Tan, Clement Luck Khng Chia, Jerry Tiong Thye Goo, Marc Weijie Ong","doi":"10.4274/ejbh.galenos.2022.2022-1-2","DOIUrl":"10.4274/ejbh.galenos.2022.2022-1-2","url":null,"abstract":"<p><strong>Objective: </strong>Patients with breast cancer who have indeterminate extra-mammary lesions, for example in lung, liver or bone, without other metastatic lesions pose a clinical dilemma regarding subsequent management. This study aimed to investigate the prevalence, characteristics and outcomes of such lesions detected on initial staging imaging, and address the clinical significance of these incidental findings.</p><p><strong>Materials and methods: </strong>Medical records of patients with newly diagnosed breast cancer who underwent computed tomography scans and bone scintigraphy between January 1, 2015 and June 30, 2021 were reviewed. Patients with indeterminate extra-mammary lesions on imaging were included. Patients with obvious metastatic disease were excluded. Lesion characteristics, breast cancer staging, duration of follow-up and natural history of disease progression were analysed.</p><p><strong>Results: </strong>The study included 52 patients with indeterminate lesions on pre-operative imaging. The median follow-up duration was 14 (range: 6-41) months. The most common site of occurrence of indeterminate lesions was the lung (60.9%) followed by the liver (26.1%). Forty-six had lesions that remained stable (88.5%), while six (11.5%) had progression to metastatic disease. Out of these six, only two (3.8%) developed metastasis in the same site as the original indeterminate lesion, whereas the remaining four developed metastases in other sites.</p><p><strong>Conclusion: </strong>Patients with breast malignancy found to have indeterminate extra-mammary lesions without obvious distant metastasis on initial staging scans are associated with a small risk of subsequently developing metastatic disease. Although most of these lesions remain quiescent, surveillance imaging is recommended because a small but significant proportion of patients with such lesions eventually harbour actual metastatic disease.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255656/pdf/ejbh-18-252.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40606407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mucormycosis of the Breast in a Patient With Breast Carcinoma After COVID-19 Pneumonia.","authors":"S P Somashekhar,&nbsp;Richa Jaiswal,&nbsp;Rohit Kumar,&nbsp;B C Ashok,&nbsp;Susmita Rakshit,&nbsp;Amit Rauthan,&nbsp;H K Karthik,&nbsp;Archa Prasad,&nbsp;Herra Islam,&nbsp;Aaron Fernandes,&nbsp;Elroy Saldahana,&nbsp;K R Ashwin","doi":"10.4274/ejbh.galenos.2022.2022-2-4","DOIUrl":"https://doi.org/10.4274/ejbh.galenos.2022.2022-2-4","url":null,"abstract":"<p><p>Mucormycosis is a rare, but potentially fatal, fungal infection which is caused by mucormyctes. These forms of fungi are typically known to infect immuno-compromised individuals but are rare in immunocompetent individuals. Herein, we report the case of a 52 year-old female who was diagnosed with right breast carcinoma in Manipal Hospital, a tertiary cancer care center. The patient was a known diabetic and hypertensive and who had recently recovered from coronavirus disease-2019 (COVID-19) pneumonia. In the due course of management, she developed mucormycosis infection at the operative site in her right breast where she had a radiation therapy-induced wound. This patient was successfully treated with an aggressive regimen of early surgical debridement along with administration of systemic amphotericin B.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255654/pdf/ejbh-18-289.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40618491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}